The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors

Published:2024-09-01 Issue:3 Volume:312 Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Mendiratta-Lala Mishal^ORCID,Wiggermann Philipp^ORCID,Pech Maciej^ORCID,Serres-Créixams Xavier,White Sarah B.^ORCID,Davis Clifford,Ahmed Osman^ORCID,Parikh Neehar D.^ORCID,Planert Mathis^ORCID,Thormann Maximilian^ORCID,Xu Zhen,Collins Zachary^ORCID,Narayanan Govindarajan,Torzilli Guido,Cho Clifford^ORCID,Littler Peter^ORCID,Wah Tze Min^ORCID,Solbiati Luigi^ORCID,Ziemlewicz Timothy J.^ORCID

Funder

National Institutes of Health

National Cancer Institute

Publisher

Radiological Society of North America (RSNA)

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.233051

Reference34 articles.

1. Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound

2. First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. AASLD guidelines for the treatment of hepatocellular carcinoma

5. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP